Skip to main content

Table 2 Distribution of GI symptoms in patients with ATTR amyloidosis

From: THAOS: Gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease

Symptom

Wild-type

TTR mutation

n = 140

n = 1114

Any GI symptom

21 (15.3%)

696 (63.0%)

Early satiety

5 (3.6%)

291 (26.4%)

Nausea

3 (2.2%)

189 (17.1%)

Vomiting

0 (0.0%)

147 (13.4%)

Constipation

5 (3.6%)

230 (20.9%)

Diarrhea/constipation

2 (1.5%)

267 (24.3%)

Diarrhea

5 (3.6%)

218 (19.8%)

Fecal incontinence

0 (0.0%)

68 (6.2%)

Unintentional weight loss

4 (2.9%)

346 (31.5%)

  1. Number of patients, n (%), reporting gastrointestinal (GI) symptoms at enrollment.